Testing effectiveness (Phase 2)Study completedNCT04930003
What this trial is testing
Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine
Who this might be right for
Covid19SARS-CoV InfectionVaccine Adverse Reaction
Research Institute for Biological Safety Problems 244